A lab test – whether DNA, biomarker panel, or microbiome screening – provides data, not diagnoses. The predictive power of many direct-to-consumer (DTC) tests is limited: they often rely on GWAS with small effect sizes that are poorly predictive for individuals. For example, SNP rs10830963 (MTNR1B) shows a statistical link to higher fasting glucose, but the effect is small and not diagnostic. Polygenic risk scores for heart disease are often inaccurate outside European ancestries and do not replace clinical risk assessment. Nutrigenomics research (cf. PMC10036735) emphasizes that gene–nutrient interactions are evolutionarily conserved, but individual impact is dominated by environment, lifestyle, and epigenetics. Marketing often exaggerates actionability: a SNP like rs5082 (APOA2) is associated with BMI and fat intake, but evidence is moderate and insufficient for specific dietary advice. Safety note: supplements based on SNP findings (e.g., rs1001179 for antioxidants) can be risky if overdosed. A lab test is a tool, not an oracle – always interpret results with medical guidance and in the context of your overall health.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-93a784c8de8eaffd601ebd19